Claritev Corporation (CTEV) - Total Liabilities
Based on the latest financial reports, Claritev Corporation (CTEV) has total liabilities worth $5.07 Billion USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Claritev Corporation - Total Liabilities Trend (2019–2025)
This chart illustrates how Claritev Corporation's total liabilities have evolved over time, based on quarterly financial data. See working capital position of Claritev Corporation to evaluate short-term liquidity relative to the company's equity base.
Claritev Corporation Competitors by Total Liabilities
The table below lists competitors of Claritev Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Fenerbahce Futbol AS
IS:FENER
|
Turkey | TL19.22 Billion |
|
Traffic Control Technology Co Ltd
SHG:688015
|
China | CN¥3.67 Billion |
|
Mekonomen AB
ST:MEKO
|
Sweden | Skr11.51 Billion |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
|
China | CN¥404.13 Million |
|
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365
|
China | CN¥247.20 Million |
|
Thaitheparos Public Company Limited
BK:SAUCE
|
Thailand | ฿294.76 Million |
|
Shivalik Bimetal Controls Limited
NSE:SBCL
|
India | Rs1.34 Billion |
|
DINGDONG CAYMAN 2ADR/3 A
F:945
|
Germany | €5.84 Billion |
Liability Composition Analysis (2019–2025)
This chart breaks down Claritev Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Claritev Corporation market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.28 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -21.04 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.05 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Claritev Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Claritev Corporation (2019–2025)
The table below shows the annual total liabilities of Claritev Corporation from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $5.06 Billion | -0.22% |
| 2024-12-31 | $5.07 Billion | -3.59% |
| 2023-12-31 | $5.26 Billion | -5.82% |
| 2022-12-31 | $5.58 Billion | -5.02% |
| 2021-12-31 | $5.88 Billion | +2.62% |
| 2020-12-31 | $5.73 Billion | -10.19% |
| 2019-12-31 | $6.38 Billion | -- |
About Claritev Corporation
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers claims intelligence solutions, including reference-based pricing, negotiation services, surprise bill services, and Vistara; network solutions, such as primary n… Read more